SELECTIVE ANTI-MARCKS TECHNOLOGIES
biomarck is developing technology that utilizes targeted anti-Marcks technology for the treatment of Cancer and Acute Respiratory Distress Syndrome (ARDS)
biomarck pharmaceuticals intends to support children with difficult to treat cancers such as Rhabdomyosarcoma and Neuroblastoma. This may be done by a compassionate use program under the Investigator IND of the treating hospital. This effort will be done in support of the concepts of non-profit organizations such as the Miami based Live Like Bella Foundation (Learn More) which supports children with cancer, their families and research into childhood cancer.